RLAY RELAY THERAPEUTICS INC
FollowStock (common), issuer CIK 1812364
Filings received so far for Q3 2026: 6 13F filers report a position in RLAY shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Patel Sanjivdirector, officer (President and CEO) | 2026-10-07 | -48,199 S | $18.1 | Form 4 |
| Catinazzo Thomasofficer (Chief Financial Officer) | 2026-10-06 | -206 S | $19.26 | Form 4 |
| Catinazzo Thomasofficer (Chief Financial Officer) | 2026-10-06 | -17,511 S | $18.58 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| CONGRESS ASSET MANAGEMENT CO | 779,544 | $14.1M | 0.09% | +153,403 | 13F-HRTimeline |
| Valeo Financial Advisors, LLC | 35,251 | $636K | 0.01% | -436 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 4,156 | $75K | <0.01% | +41 | 13F-HRTimeline |
| GAMMA Investing LLC | 2,850 | $51.4K | <0.01% | +1,482 | 13F-HRTimeline |
| Versant Capital Management, Inc | 559 | $10.1K | <0.01% | 0 | 13F-HRTimeline |
| MassMutual Private Wealth & Trust, FSB | 81 | $1.46K | <0.01% | new | 13F-HRTimeline |
Events
Patel Sanjiv sold 48,199 RLAY shares on 2026-10-07, Form 4 filed 2026-10-08. 0001193125-26-418096
Accepted , ingestedCatinazzo Thomas sold 17,717 RLAY shares on 2026-10-06, Form 4 filed 2026-10-08. 0001193125-26-418094
Accepted , ingested